金石亚药 (300434)

Sichuan Goldstone Asia Pharmaceutical Inc.

ASZ

Tags

Contract Research Organization (CXO)Public-Private Partnership (PPP) ConceptInnovative DrugsPharmaceutical ManufacturingUnderground Pipeline NetworksInfant and Child ConceptSmall Cap Non-FinancialNew Private Equity HoldingsVitaminsEnergy Conservation and Environmental Protection

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 40174.39
  • Circulating A-Shares(W): 34212.11
  • Earnings Per Share(RMB): 0.2400
  • Net Assets Per Share(RMB): 6.2653
  • Operating Revenue(W RMB): 70844.55
  • Total Profit(W RMB): 11241.18
  • Net Profit Attributable to Parent(W RMB): 9676.59
  • Net Profit Growth Rate(%): 66.47
  • Weighted Return on Equity(%): 3.8900
  • Operating Cash Flow Per Share(RMB): 0.3770
  • Undistributed Profit Per Share(RMB): 0.6378
  • Capital Reserve Per Share(RMB): 4.4488

2. Main Business

The main business covers:

  • R&D, production, and sales of over-the-counter (OTC) drugs
  • R&D, production, and sales of prescription drugs
  • R&D, production, and sales of active pharmaceutical ingredients (APIs)
  • R&D, production, and sales of health foods

3. Company Basic Information

  • Company Name: Sichuan Goldstone Asia Pharmaceutical Inc.
  • Listing Date: 2015-04-24
  • Industry: Pharmaceutical Manufacturing
  • Address: 8F, Block A1, Dadi Xinguanghua Plaza, No.8 Jiayuan Road, Qingyang District, Chengdu, Sichuan; Yake Center, No.4760 Jiangnan Avenue, Binjiang District, Hangzhou, Zhejiang
  • Website: www.goldstone-group.com
  • Company Profile: The company was formerly known as Sichuan Goldstone Oriental New Materials & Equipment Co., Ltd. and was restructured into a joint-stock company in 2011. The company is primarily engaged in the R&D, production, and sales of over-the-counter drugs, prescription drugs, active pharmaceutical ingredients, and health foods.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhejiang Dier Investment Co., Ltd. General Legal Person 1456.44 4.26
2 Hainan Yadongnan Industry and Trade Co., Ltd. General Legal Person 815.55 2.38
3 Shanghai Tongyi Investment Management Co., Ltd. - Tongyi Furong No.19 Private Securities Investment Fund Private Securities Investment Fund 167.52 0.49

5. Concept Sectors

  • Energy Conservation & Environmental Protection
  • Infant & Child Concept
  • Vitamins
  • PPP Concept
  • Underground Pipeline Network
  • CXO Concept
  • Innovative Drugs
  • Small Cap Non-Marginable
  • Private Placement New Entry

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information